Related Experiment Video

Updated: Jun 4, 2025

Monitoring eIF4F Assembly by Measuring eIF4E-eIF4G Interaction in Live Cells
08:47

Monitoring eIF4F Assembly by Measuring eIF4E-eIF4G Interaction in Live Cells

Published on: May 1, 2020

3.0K

Elongation factor 2 in cancer: a promising therapeutic target in protein translation

Xuechao Jia1,2, Chuntian Huang1,3, Fangfang Liu4

  • 1Henan International Joint Laboratory of TCM Syndrome and Prescription in Signaling, Traditional Chinese Medicine (Zhong Jing) School, Henan University of Chinese Medicine, Zhengzhou, 450046, Henan, China.

Cellular & Molecular Biology Letters
|December 20, 2024
PubMed

Insights

Aberrant protein elongation, often involving eukaryotic elongation factor 2 (eEF2), can drive cancer. This review explores eEF2

Area of Science:

  • Molecular Biology
  • Biochemistry
  • Cancer Research

Background:

  • Aberrant protein elongation is implicated in oncogenic signaling pathways.
  • Eukaryotic elongation factor 2 (eEF2) regulates protein synthesis and peptide elongation.
  • Existing research on eEF2 has predominantly focused on its structure, necessitating deeper investigation into its molecular functions.

Purpose of the Study:

  • To summarize recent advancements in understanding eEF2.
  • To explore the molecular functions, regulatory mechanisms, and therapeutic potential of eEF2 in cancer.

Main Methods:

  • Literature review of recent scientific advancements.
  • Synthesis of data on eEF2 structure, GTPase activity, and posttranslational modifications.
  • Analysis of regulatory factors and inhibitors impacting eEF2 function.

Main Results:

  • Comprehensive overview of eEF2's structure, guanosine triphosphatase (GTPase) activity, and posttranslational modifications.
  • Identification of key regulatory factors and inhibitors influencing eEF2.
  • Consolidation of knowledge regarding eEF2's critical role in cellular processes.

Conclusions:

  • eEF2 plays a critical role in cancer development and progression.
  • Understanding eEF2's molecular functions offers potential for novel cancer therapeutics.
  • Further research is needed to address outstanding questions regarding eEF2's role and therapeutic targeting.
Keywords:
CancerElongation factor 2InhibitorsProtein elongationRegulators

More Related Videos

Toeprinting Analysis of Translation Initiation Complex Formation on Mammalian mRNAs10:37

Toeprinting Analysis of Translation Initiation Complex Formation on Mammalian mRNAs

Published on: May 10, 2018

12.4K
Analysis of Translation Initiation During Stress Conditions by Polysome Profiling10:59

Analysis of Translation Initiation During Stress Conditions by Polysome Profiling

Published on: May 19, 2014

18.2K

Related Concept Videos

Improving Translational Accuracy02:07

Improving Translational Accuracy

Base complementarity between the three base pairs of mRNA codon and the tRNA anticodon is not a failsafe mechanism. Inaccuracies can range from a single mismatch to no correct base pairing at all. The free energy difference between the correct and nearly correct base pairs can be as small as 3 kcal/ mol. With complementarity being the only proofreading step, the estimated error frequency would be one wrong amino acid in every 100 amino acids incorporated. However, error frequencies observed in...
8.8K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.4K
Transcription Elongation Factors02:35

Transcription Elongation Factors

Transcription elongation is a dynamic process that alters depending upon the sequence heterogeneity of the DNA being transcribed. Hence, it is not surprising that the elongation complex's composition also varies along the way while transcribing a gene.
The transcription elongation is regulated via pausing of RNA polymerase on several occasions during transcription. In bacteria, these halts are necessary because the transcription of DNA into mRNA is coupled to the translation of that mRNA...
10.7K
Leaky Scanning02:28

Leaky Scanning

During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA.  Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.1K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.7K